Jason Cavalier - 13 Sep 2021 Form 3 Insider Report for Lyra Therapeutics, Inc. (LYRA)

Role: Chief Financial Officer
Signature: /s/ Jason Cavalier
Issuer symbol: LYRA
Transactions as of: 13 Sep 2021
Net transactions value: $0
Form type: 3
Filing time: 15 Sep 2021, 17:40:40 UTC
Next filing: 15 Feb 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney.